Family: | Direxion Shares |
Name: | Direxion Daily S&P Biotech Bear 3x Shares |
Inception Date: | 28-May-2015 |
Termination Date: | |
Investment Objective: | The Fund seeks daily investment results, before fees and expenses, of 300% of the inverse (or opposite) of the performance of the S&P Biotechnology Select Industry Index. The Index is provided by Standard & Poor s and includes domestic companies from the biotechnology industry. As of April 30, 2015, the Index was comprised of 98 stocks. The companies included in the Index have a median market capitalization of $1.54 billion and are concentrated in the energy and biotechnology sectors as of April 30, 2015. |
Prospectus | |
Top 10 Holdings | ||
Derivatives offset | 309.8925% | |
S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP | -90.1848% | |
S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP | -52.7873% | |
S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP | -46.6030% | |
S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP | -44.9386% | |
S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP | -43.8343% | |
GOLDMAN FINL SQ TRSRY INST 506 | X9USDGSFC | 42.3686% |
DREYFUS GOVT CASH MAN INS | X9USDDGCM | 40.4211% |
S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP | -31.5446% | |
DREYFUS TRSRY SECURITIES CASH MGMT | 8.7381% | |
Top 10 Holdings Weight: | 91.5% |
Number of Holdings: | 11 |
Shares Outstanding: | 11,366,024 |
Total Net Assets: | 92,519,430 |
NAV: | 8.13 |
Net Expense Ratio: | 0.95% |
Asset Class: | Equities (Stocks) |
Developed or Emerging: | Developed Market Funds |
Country: | US |
Region: | |
Strategy: | |
Currency: | |
Commodity: | |
Sector: | Healthcare |
Industry: | Biotech |
Dividend Type: | |
Tax Exempt State: | |
Maturity Duration: | |
Market Cap: | Broad Market / Multi-Cap |
Credit Quality: | |
Mortgage Bond Types: | |
Bond Type: | |
Gov't Bond Types: | |
Reit Type: | |
Leverage Direction/Factor: | Inverse (-3x) |
Is Currency Hedged: | No |
US or Ex-US: | Domestic |